Wound care

The year of proof: Clinical trial shows dressings1 have an important role to play in preventing hospital acquired pressure ulcers

By: Mölnlycke Health Care, November 4 2013Posted in: Wound care

Hospital acquired pressure ulcers are a major challenge for medical practitioners. If identified early, they can often be treated swiftly but if left unnoticed they can be extremely painful and debilitating for patients. If allowed to develop, they can also have a significant financial impact on healthcare trusts and operators, with the cost of treatment in the UK ranging from GBP 1,064 (Stage I) to GBP 10,551 (Stage IV) per patient2.

Pressure ulcers may develop as a result of many contributing factors, including the mechanical effects of pressure, shear, friction and / or moisture on the skin.  Within emergency departments (ED) and intensive care units (ICU), where patients are already suffering from other acute or emergency medical conditions, these factors are more prevalent than in any other part of the hospital environment.

The year of proof: results from randomised control trial

Traditional pressure ulcer prevention protocols, including using special support surfaces, patient rotation, improved nutrition and, of course, regular skin inspections may still result in a pressure ulcer prevalence of some 13%3.

A study by Professor Nick Santamaria of the University of Melbourne & Royal Melbourne Hospital, recently published in the International Wound Journal4, has now demonstrated the important role that silicone foam dressings such as Mölnlycke Health Care's Mepilex® Border Sacrum and Mepilex® Heel play in preventing the development of pressure ulcers in an ED and ICU environment.

The study followed 440 trauma and critically ill patients who were admitted to the emergency department and subsequently transferred to the intensive care unit.  Mepilex Border Sacrum and Heel dressings were applied to patients in the intervention group (221 patients) on admission to the ED, inspected daily and changed every three days in the ICU.  The control group patients (219) were subjected to standard pressure ulcer prevention procedures.

Of the patients in the intervention group five developed pressure ulcers, an incidence of 3.1%.  In the control group, 20 developed patients pressure ulcers, an incidence of 13.1%.

In addition to the reduction in pressure ulcers, researchers also reported that the treatment was cost-effective. The total cost for treating patients in the control group was USD 25,173 whilst the total treatment costs for the intervention group was only USD 6,920, over 70% lower.

Professor Nick Santamaria from the University of Melbourne & Royal Melbourne Hospital comments on the results of his study:

"The results of this large RCT demonstrate that by intervening as soon as the patient reaches the hospital we are able protect this vulnerable group throughout their stay in hospital.  This includes time spent in the Imaging Department and the Operating Room. The dressings from Mölnlycke Health Care offer clinicians an important additional preventative treatment for stopping hospital acquired pressure ulcers."

Tod Brindle awarded for work in pressure ulcer prevention

Tod Brindle, a nurse clinician at the Virginia Commonwealth University Health one of the pioneers of facilitating procedural changes to help reduce the prevalence of hospital acquired pressure ulcers, has been rewarded for his work by the American Nurses Credentialing Center (ANCC).  He was recently awarded the ANCC’s award the National Magnet Nurse of the year Award for his contributions to a hospital-wide practice change that has led to a reduction in hospital acquired pressure ulcers from 8% to 2.4%5.

Jill McLean, Global Therapy Manager for Prevention at Mölnlycke Health Care, said:

"I'm delighted to see Tod Brindle’s innovative and original work, using Mepilex Border dressings for prevention, being furthered into strong, clinical evidence that can be used to develop new standards of practice and help prevent pressure ulcers around the world."

21 November 2013: Stop Pressure Ulcer Day

Mölnlycke Health Care is proud to be supporting the European Pressure Ulcer Advisory Board's annual Stop Pressure Ulcer Day, being held on 21 November, 2013.

For the second straight year, Mölnlycke Health Care will be hosting a webinar in conjunction Stop Pressure Ulcer Day.  The event, entitled "The Year of Proof", will focus on the clinical trials published during the last twelve months, with a particular focus on the use of wound dressings as a means of hospital acquired pressure ulcer prevention.  What are the contributing causes of pressures ulcers? How can dressings play an active role in preventing them? Can the use of dressings become a new standard of care?

These are some of the questions that Professor Carol Dealey of the University of Birmingham will discuss during the evidence-based and solution-focused event.  Other guest speakers include Professor Nick Santamaria, Evan Call and Tod Brindle. Visit European Pressure Ulcer Advisory Panel's website to read more about Stop pressure ulcer day.

Download a infographic about pressure ulcers (pdf, 246 KB)

 

References:

  1. As an adjunct to current prevention protocols.
  2. Bennett, G., et al. The cost of pressure ulcers in the UK. Age Ageing 2004, 33(3): 230-235.
  3. Kalowes, P., et al. Use of a soft silicone, self-adherent, bordered foam dressing to reduce pressure ulcer formation in high risk patients: a randomized clinical trial. Poster presentation at Symposium on Advanced Wound Care (Fall), Baltimore, Maryland, United States of America, 2012.
  4. International Wound Journal, March 2013.
  5. Brindle, C.T., Wegelin, J.A., Prophylactic dressing application to reduce pressure ulcer formation in cardiac surgery patients.  Journal of Wound Care Ostomy & Continence Nursing 2012; 39(2): 133-142.
Share this

More from the same category

Mextra Superabsorbent

Our new Superabsorbent Wound care dressing is here! Its design is based on a unique 4-layer construction...

Meet us at EWMA 23-25 May 2012 in Vienna

We exhibit at EWMA as Corporate A Sponsors to show how our wide range of...

Ask the Experts about about the role...

Some of the world’s leading experts will take part in an outstanding symposium...

Mölnlycke Health Care acquires innovative...

Mölnlycke Health Care announces that it has acquired a pioneering electrical...

Mölnlycke Health Care Wound care - Exhibits...

Mölnlycke Health Care will take part in World Union of Wound Healing Societies...

Molnlycke.com now offers even more knowledge...

We are proud to present “Ask the experts”, the latest feature in the Knowledge...

Join us or follow us online during WUWHS...

We look forward to meeting you at the World Union of Wound Healing Societies...

WUWHS 2012 is now open!

From today the 3rd of Sept until the 6th of Sept Mölnlycke Health Care will be delighted to meet...

Dr Evan Call on the difference between...

On the 3rd of September Mölnlycke Health Care, together with some of the...

Wendy White on the topic pain as a universal...

On the 5th of September Mölnlycke Health Care, together with some of the...

Mepilex Border Heel

  // The well established and highly successful product range of Mepilex® Border continues to grow...

Do you know about Stop Pressure Ulcer...

This annual day aims to raise awareness of the global burden of pressure...

Stop Pressure Ulcers

Did you know that Stop Pressure Ulcer Awareness Day is happening this Friday 16 November? This...

EWMA pressure ulcer symposium report:...

The EWMA delegates who attended the Mölnlycke Health Care seminar on pressure...

Mepilex Transfer Ag

The efficacy of wound contact layer dressings with antimicrobial properties in clinical wound care...

Mepilex Border Post-Op

The need for a reliable, surgically safe post-operative wound dressing for both clinical and patient...

EWMA 2013

EWMA 2013 in Copenhagen, Denmark, is set to become the best-attended wound care conference ever...

Introducing Mepilex Border Flex

The Mepilex® Border product range has just become more versatile than...

Mölnlycke Health Care welcomes you to...

Every day we will "share our care" by presenting you different views on...

Construction matters: The use of multilayer...

During this year's World Union congress in Yokohama, Japan C Tod Brindle...

Mepilex Ag - A key element in wound...

A recently published French study has confirmed the effectiveness of Mepilex®...

EWMA symposium report: Examining how...

Several hundred EWMA delegates attended the Mölnlycke Health Care symposium,...

International DEBRA Congress 2013

Epidermolysis bullosa (EB) is a rare, inherited skin disorder which causes...

Mölnlycke Health Care presents pain...

Mölnlycke Health Care participated in two interesting congresses in Vienna,...

Mölnlycke Health Care proud sponsor...

Mölnlycke Health Care recently had the honour of sponsoring the 2013 DEBRA...

ISPeW congress 2013

It is approximately one week until the inter-annual  ISPeW meeting in Miami, US. The International...

EWMA 2014

Mölnlycke Health Care has always been creating a legacy of leading the way in wound care management,...

Influencing cost effective wound care

Mölnlycke Health Care has chosen "Leading the way in innovation and evidence"...

Study showing that Mepitel Film prevents...

Radiation-induced skin reactions occur in 80-90 percent of breast cancer...

Summarizing EWMA 2014 in Madrid

As in previous years, delegates who attended the EWMA 2014 Conference in...

EPUAP conference 2014

Mölnlycke Health Care will participate as corporate sponsors at EPUAP (European Pressure Ulcer Advisory...

ISBI congress 2014

This month, Mölnlycke Health Care has been attending, hosting dedicated events and been platinum...

EWMA 2015

One of the best showcases for innovation is in the sharing of knowledge and best practices, and...

EWMA 2015 recap

The annual European Wound Management Association (EWMA) event gives Mölnlycke Health Care the opportunity...

GlucanPro 3000 and GlucanPro Cream changing...

Mölnlycke Health Care has announced that it will no longer offer GlucanPro®...

Proven prevention: Proof into practice...

Hospital acquired conditions, such as pressure ulcers, are expensive and,...

Mepilex Border Post-Op wins Health Product...

Mölnlycke Health Care is proud to announce that Mepilex® Border Post-Op has...

New pressure ulcer prevention monograph...

Hospital-acquired conditions are a strategic focus area for Mölnlycke Health...